Phagos

Phagos develops a solution against the silent pandemic of antibiotic resistance.

The company developed an ML-driven bio platform unlocking unprecedented bacteriophage efficiency. Phagos combines ML predictive ability and optimised microbiology workflows to produce scalable, personalised phage therapies as an alternative to antibiotics.

Their first market focus is the biggest consumer of antibiotics in the world: animals.